#	Pagina
attuale pagina	/open-h2020/projects/211551/index.html
-1	/open-h2020/projects/195565/index.html
-2	/open-h2020/projects/195651/index.html
-3	/open-h2020/projects/209182/index.html

Opendata, web and dolomites

ZEBRAONCOFISH SIGNED

Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

ZEBRAONCOFISH project word cloud

Explore the words cloud of the ZEBRAONCOFISH project. It provides you a very rough idea of what is the project "ZEBRAONCOFISH" about.

tailor healthcare hospitals biology individual guide acquired tax close difficulty personalized complexity vivo found xenotransplantation disease 35 assays directed people lab therapeutic tubes influence leader dynamic team living transplant metabolic biotechnological tumor estimations million company complete interventions differently made market interspecies underlying solution anticancer 425 roadmap display opportunity drugs presented chance avatars human performed genetic zebrafish zebraoncofish patient remarkable morbidity approx cancerous created treatment cancer platform samples biological mortality understand thanks profile treatments progression decisions ultimate subjacent time makeup carry effect mean solutions extensive mechanism actionable cell lines deaths commercialization therapy onset

Project "ZEBRAONCOFISH" data sheet

The following table provides information about the project.

Coordinator	IKAN BIOTECH S.L. Organization address address: CALLE CHAPITELA 20 1 city: PAMPLONA postcode: 31001 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://zebraoncofish.com/
Total cost	2˙004˙583 €
EC max contribution	2˙004˙583 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-2-2016-2017
Funding Scheme	SME-2
Starting year	2017
Duration (year-month-day)	from 2017-09-01 to 2020-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	IKAN BIOTECH S.L. IKAN BIOTECH S.L. Organization address address: CALLE CHAPITELA 20 1 city: PAMPLONA postcode: 31001 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (PAMPLONA)	coordinator	2˙004˙583.00

Map

Project objective

The Zebrafish Lab is a biotechnological company leader in the development and commercialization of novel, tailor-made solutions based on in vivo zebrafish assays. Thanks to the extensive knowledge acquired by the R&D projects performed in the field by our team for many years and a close collaboration with Hospitals and Cancer Research Institutions, we have identified a remarkable opportunity in the ZEBRAONCOFISH project that will mean a 5-year after tax-R.O.I of 425% according to our estimations. The ultimate goal of the project presented as ZEBRAONCOFISH is to complete the technical roadmap required to bring to the healthcare market a novel real time in vivo platform for personalized cancer treatment based on the use of zebrafish “avatars” as personalized, living test tubes. Cancer is a leading cause of morbidity and mortality with approx. 35 million people affected by this disease and more than 8 million deaths per year. A major difficulty found in effective cancer treatment is the complexity of the biological mechanism underlying cancer onset and disease progression. This is because the genetic makeup and metabolic profile of each individual patient influence the effect of anticancer drugs. As such, different people respond differently to the same therapy. The solution we propose in the ZEBRAONCOFISH project is the use of zebrafish avatars as an in vivo platform to guide therapeutic decisions in actionable cancer patient-directed interventions. These avatars will be created by xenotransplantation (interspecies transplant) of human cancer cell lines/ tumor samples in zebrafish. The chance to carry out a dynamic display of the cancerous process in vivo will offer the unique opportunity to understand the subjacent cancer biology and design tailor-made treatments for each patient.

Deliverables

List of deliverables.
ZEBRAONCOFISH webpage	Websites, patent fillings, videos etc.	2020-04-24 04:18:30

Take a look to the deliverables list in detail: detailed list of ZEBRAONCOFISH deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2018	Letrado P, de Miguel I, Lamberto I, DÃez-MartÃnez R, Oyarzabal J. Zebrafish: Speeding up the Cancer Drug Discovery Process. published pages: , ISSN: 0008-5472, DOI:	Cancer Research	2020-04-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ZEBRAONCOFISH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ZEBRAONCOFISH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development